AstraZeneca India to sell its 64 acre production facility in Bengaluru
Biopharmaceutical firm AstraZeneca's Indian arm, AstraZeneca Pharma India Limited, plans to sell its 64-acre production facility in North Bengaluru. The firm is likely to get Rs 3200 crore from the sale.
The sale is a part of the strategic review of its global manufacturing and supply network conducted by its parent company. This is also a part of its broader corporate land monetization plan.
Also Read: 5 Asthma clinics in India to be set by AstraZeneca